News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
60,593 Results
Type
Article (6181)
Company Profile (6)
Press Release (54406)
Section
Business (19172)
Career Advice (323)
Deals (2391)
Drug Delivery (4)
Drug Development (6977)
Employer Resources (29)
FDA (1057)
Job Trends (1365)
News (29896)
Policy (1903)
Tag
Academia (889)
Africa (92)
Allergies (12)
Alliances (3619)
Alzheimer's disease (73)
Approvals (1057)
Arizona (15)
Artificial intelligence (4)
Asia (2610)
Australia (524)
Bankruptcy (5)
Best Places to Work (1049)
Breast cancer (7)
C2C Services and Suppliers (5198)
California (121)
Canada (60)
Cancer (27)
Cardiovascular disease (7)
Career advice (286)
Cell therapy (6)
China (8)
Clinical research (5614)
Collaboration (9)
Connecticut (6)
COVID-19 (212)
CRISPR (4)
Cystic fibrosis (9)
Data (22)
Diabetes (7)
Diagnostics (667)
Diversity, equity & inclusion (17)
Earnings (3033)
Employer resources (27)
Europe (19169)
Events (8725)
Executive appointments (24)
FDA (1063)
Florida (15)
Funding (11)
Gene editing (8)
Gene therapy (8)
GLP-1 (43)
Government (257)
Healthcare (2214)
Hotbed/Location (34454)
Illinois (25)
Indiana (9)
Infectious disease (212)
Inflammatory bowel disease (10)
Interviews (43)
IPO (1105)
Japan (6)
Job creations (323)
Job search strategy (247)
Layoffs (15)
Legal (290)
Lung cancer (5)
Management (6)
Maryland (11)
Massachusetts (104)
Medical device (1044)
Medtech (1044)
Mergers & acquisitions (1290)
Metabolic disorders (15)
Minnesota (15)
Neuroscience (82)
New Jersey (35)
New York (41)
NextGen Class of 2024 (735)
Non-profit (666)
North Carolina (82)
Northern California (67)
Obesity (9)
Ohio (6)
Opinion (15)
Peanut (11)
Pennsylvania (28)
People (11001)
Phase I (1396)
Phase II (2201)
Phase III (2180)
Pipeline (5)
Postmarket research (431)
Preclinical (624)
Rare diseases (10)
Real estate (532)
Recruiting (7)
Regulatory (1404)
Research institute (465)
Resumes & cover letters (48)
Series A (4)
South America (108)
Southern California (46)
Startups (384)
Texas (15)
United States (589)
Utah (5)
Vaccines (34)
Washington State (25)
Webinars (7)
Date
Today (10)
Last 7 days (52)
Last 30 days (155)
Last 365 days (3038)
2024 (1877)
2023 (3374)
2022 (3984)
2021 (4791)
2020 (4764)
2019 (5661)
2018 (3957)
2017 (3114)
2016 (3096)
2015 (3460)
2014 (2664)
2013 (2261)
2012 (2372)
2011 (2392)
2010 (2275)
60,593 Results for "imperial college london".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Evonetix Places First DNA Synthesis Development Platform at Imperial College London
EVONETIX LTD, the Company developing semiconductor scale technology to improve access to gene synthesis, announced its first placement of a DNA synthesis development platform for evaluation at Imperial College London.
October 4, 2023
·
2 min read
BioMidwest
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
Aclarion, Inc. announced their initial payer coverage of Nociscan by AXA in London, UK in conjunction with The London Clinic, one of the UK’s largest and most renowned independent hospitals.
June 26, 2024
·
4 min read
Press Releases
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
July 15, 2024
·
4 min read
Business
Recursion Announces Plans to Open New Office in London
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced plans to open a new office in London’s vibrant King’s Cross neighborhood.
March 11, 2024
·
6 min read
Cytomos offers sneak preview of flagship technology at the London Biotechnology Show 2024
1st May 2024: TechBio company Cytomos (www.cytomos.com) will be giving visitors to this year’s London Biotechnology Show a sneak preview of Celledonia™ – its flagship technology that utilises the company’s patented AuraCyt™ platform.
May 1, 2024
·
3 min read
Genetown
Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening
Mercy BioAnalytics, Inc. will present data at the American Society of Clinical Oncology Annual Meeting next month demonstrating the first significant improvement in the early detection of ovarian cancer using a locked assay since CA125 serum biomarker testing and transvaginal ultrasound imaging were introduced nearly 40 years ago.
May 23, 2024
·
6 min read
Biotech Bay
UCSF QBI, University College London, and Mount Sinai Identify Shared Molecular Mechanisms Across SARS-CoV-2 Variants that Allow Virus to Thrive Despite Vaccination
In a study published online in CELL , scientists at UCSF QBI, University College London and the Icahn School of Medicine at Mount Sinai reported breakthrough findings on convergent evolutionary mechanisms shared by COVID-19 variants, allowing them to overcome both adaptive and innate immune system barriers.
September 21, 2023
·
10 min read
Business
Stallergenes Greer Strengthens Precision Medicine Approach in Allergen Immunotherapy With Imperial College London Research Collaboration
Stallergenes Greer today announced that the company has entered into a research collaboration on the discovery of biomarkers of AIT efficacy with Imperial College London, a global top ten university with a world-class reputation in science, engineering, business and medicine.
January 17, 2022
·
3 min read
Business
Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board
Tessellate BIO announces the appointment of Professor Sandra Strauss, University College London, to its Scientific Advisory Board.
May 1, 2024
·
4 min read
BioMidwest
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
Co-Diagnostics, Inc. announced that Co-Dx CEO Dwight Egan will deliver the keynote address at the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets and held March 21-22, 2024, in London, England.
March 18, 2024
·
2 min read
1 of 6,060
Next